These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7001884)

  • 1. Cytotoxicity of Shigella dysenteriae 1 for cultured mammalian cells.
    Hale TL; Formal SB
    Am J Clin Nutr; 1980 Nov; 33(11 Suppl):2485-90. PubMed ID: 7001884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of Shiga toxin and other cytotoxins by serogroups of Shigella.
    Bartlett AV; Prado D; Cleary TG; Pickering LK
    J Infect Dis; 1986 Dec; 154(6):996-1002. PubMed ID: 3537154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
    Sandvig K; Olsnes S; Brown JE; Petersen OW; van Deurs B
    J Cell Biol; 1989 Apr; 108(4):1331-43. PubMed ID: 2564398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin.
    Jacewicz M; Keusch GT
    J Infect Dis; 1983 Nov; 148(5):844-54. PubMed ID: 6355319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.
    Neill RJ; Gemski P; Formal SB; Newland JW
    J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.
    O'Brien AD; LaVeck GD; Thompson MR; Formal SB
    J Infect Dis; 1982 Dec; 146(6):763-9. PubMed ID: 6754826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
    Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
    J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential virulence of viable but nonculturable Shigella dysenteriae type 1.
    Rahman I; Shahamat M; Chowdhury MA; Colwell RR
    Appl Environ Microbiol; 1996 Jan; 62(1):115-20. PubMed ID: 8572688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    Jacewicz MS; Mobassaleh M; Gross SK; Balasubramanian KA; Daniel PF; Raghavan S; McCluer RH; Keusch GT
    J Infect Dis; 1994 Mar; 169(3):538-46. PubMed ID: 8158025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
    Obrig TG; Del Vecchio PJ; Brown JE; Moran TP; Rowland BM; Judge TK; Rothman SW
    Infect Immun; 1988 Sep; 56(9):2373-8. PubMed ID: 3044997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin.
    Donohue-Rolfe A; Jacewicz M; Keusch GT
    Mol Microbiol; 1989 Sep; 3(9):1231-6. PubMed ID: 2677606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
    Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups.
    Cleary TG; Mathewson JJ; Faris E; Pickering LK
    Infect Immun; 1985 Jan; 47(1):335-7. PubMed ID: 3880727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells.
    Jacewicz M; Feldman HA; Donohue-Rolfe A; Balasubramanian KA; Keusch GT
    J Infect Dis; 1989 May; 159(5):881-9. PubMed ID: 2651533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry of Shigella dysenteriae toxin into HeLa cells.
    Eiklid K; Olsnes S
    Infect Immun; 1983 Nov; 42(2):771-7. PubMed ID: 6358031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin.
    Brown JE; Rothman SW; Doctor BP
    Infect Immun; 1980 Jul; 29(1):98-107. PubMed ID: 6156915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys.
    Shibolet O; Shina A; Rosen S; Cleary TG; Brezis M; Ashkenazi S
    FEMS Immunol Med Microbiol; 1997 May; 18(1):55-60. PubMed ID: 9215587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.